| COVANCE TO PRESENT AT FALL HEALTHCARE CONFERENCES |
 |
Princeton, New Jersey, September 4, 2003 — Covance Inc. (NYSE: CVD) announced that it will participate in two upcoming healthcare conferences in September 2003. Chris Kuebler, Covance's Chairman and Chief Executive Officer, will make a formal presentation at the Bear Stearns 16th Annual Healthcare Conference in New York City on Tuesday, September 9 at 4:00 p.m. EST. Bill Klitgaard, Covance's Chief Financial Officer, will present at the UBS Warburg Global Life Sciences Conference in New York City on Wednesday, September 24 at 2:00 p.m. EST.
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 2002 net revenues of $883 million, global operations in 18 countries, and approximately 6,800 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the website in the About Covance area. |
|
|
